conclusions: this study highlighted the need to establish antimicrobial resistance surveillance networks for p. aeruginosa to determine the appropriate empirical treatment regimens. the high prevalence of multidrug resistance and production of esbls in p. aeruginosa isolates confirms the necessity of protocols considering these issues in the hospitals. results: the resistance against broad-spect...

Detection of AmpC and ESBL producing P. aeruginosa by phenotypic methods is challenging, especially in low-income countries such as Pakistan. Therefore, a molecular method was developed for rapid detection these resistance markers. A total 303 clinical samples were collected from intensive care units (ICUs) the Jinnah postgraduate medical centre (JPMC) Karachi, The isolates identified tradition...

BACKGROUND Drug-resistant Providencia rettgeri producing metallo-β-lactamase and 16S rRNA methylase has been reported in several countries. We analyzed P. rettgeri clinical isolates with resistance to carbapenems and aminoglycosides in a hospital in Nepal. METHODS Five clinical isolates of multidrug-resistant P. rettgeri were obtained in a hospital in Nepal. Antimicrobial susceptibilities wer...

A clinical Providencia stuartii isolate SM662 was recovered from a patient hospitalized in the intensive care unit at the Military hospital, Tunisia. This isolate was resistant to penicillins, cephalosporins, aminoglycosides and fluoroquinolones. A marked in vitro synergy between ceftazidime or cefotaxime and amoxicillin-clavulanic acid on Mueller-Hinton agar plates suggested the presence of an...